A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis. - Vachhani P; Tan P; Watson AM; Wu SJ; Baker R; Cheung S; Lee SE; Chen CC; Chen TY; Hsiao HH; Lee JH; Masarova L; et al. (Haematologica, 2025)